{"id":11210,"date":"2017-06-26T00:00:00","date_gmt":"2017-06-26T00:00:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/media-room\/cri-announces-1-million-technology-impact-award-recipient\/"},"modified":"2022-07-13T04:19:07","modified_gmt":"2022-07-13T04:19:07","slug":"cri-1-million-technology-impact-award-recipient","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/cri-1-million-technology-impact-award-recipient","title":{"rendered":"CRI Announces $1 Million Technology Impact Award Recipient"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

The Cancer Research Institute (CRI), the world\u2019s leading nonprofit organization dedicated exclusively to advancing scientific efforts to develop new and effective immunotherapies for all forms of cancer, announced today that Dongeun Huh, PhD, of the Department of Bioengineering at the University of Pennsylvania will receive the inaugural CRI Technology Impact Award. The $1 million grant paid over three years\u2014the largest grant CRI has awarded to a single investigator at one time\u2014will support Dr. Huh\u2019s development of microchip-based research models that mimic human cancer and immune cell interactions, a technological innovation with significant potential to accelerate the development of effective immunotherapies for all cancers.<\/p>\n\n\n\n

\u201cThere is an urgent need within the research community for new ways to model, observe, and interrogate complex interactions between the human immune system and tumors\u2014a dynamic interplay that current two-dimensional cell cultures and animal models cannot characterize optimally,\u201d said Jill O\u2019Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute.<\/p>\n\n\n\n

\u201cDr. Huh\u2019s microchip-based human cancer models represent a highly innovative intersection of cell biology and microengineering, which, when applied to cancer immunotherapy research, may spur advances in our understanding of how malignant human tumors interact with the immune system and surrounding tissues, providing researchers with new insights that will lead to improved cancer treatments,\u201d O\u2019Donnell-Tormey added.<\/p>\n\n\n\n

The CRI Technology Impact Award<\/a> offers an opportunity for scientists to collaborate across disciplines on high-risk, high-reward research projects. The award enables cross-fertilization of expertise, ideas, and technologies\u2014in this case, attracting an accomplished expert in bioengineering to the field of cancer immunotherapy. To carry out this ambitious project, Dr. Huh has teamed up with two immunologists at the University of Pennsylvania, E. John Wherry, PhD, and G. Scott Worthen, MD, who will oversee the investigation of cancer-immune cell interactions using Dr. Huh\u2019s technology.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Harnessing novel bioengineering technology, Dr. Huh and colleagues will apply microfabrication techniques originally developed for making computer chips to create a \u201ccancer-on-a-chip\u201d microdevice that enables culture of patient cancer cells. The model will be engineered to form a network of living blood vessels that simulate the same vessels that immune cells use to circulate within the human body. Using this novel platform, Dr. Huh will study the interactions between cancer cells with key components of the immune system involved in cancer elimination such as macrophages and T cells.<\/p>\n\n\n\n

In addition to providing new insights that may lead to novel strategies to treat cancer with immunotherapy, Dr. Huh\u2019s model may also function as a screening platform to test and predict the efficacy and safety of drugs without first requiring them to be tested in patients. <\/p>\n\n\n\n

\u201cDr. Huh\u2019s proposal is truly exciting in terms of its potential to make an impact on how cancer immunotherapy research is conducted as well as how we predict patient response to immunotherapy. This is sorely needed, and we also think this project could help us develop strategies that will extend the benefits of immunotherapy to more and more patients,\u201d said Mark M. Davis, PhD, professor of microbiology and immunology at the Stanford University School of Medicine and chair of a specially-convened scientific review committee that evaluated proposals submitted to compete for the award. <\/p>\n\n\n\n

In addition to Dr. Davis, other esteemed members of the scientific review committee included Jeffrey Hammerbacher of Mount Sinai, James R. Heath, PhD, of the University of California, Los Angeles, Darrell J. Irvine, PhD, and J. Christopher Love, PhD, of the Massachusetts Institute of Technology, Matthew Krummel, PhD, of the University of California, San Francisco, and Ton Schumacher, PhD, of The Netherlands Cancer Institute.<\/p>\n\n\n\n\n\n

About the Tech Impact Award<\/strong>
The Cancer Research Institute Technology Impact Award is a new program designed to challenge the world’s leading scientists and out-of-the box thinkers to create a research plan and assemble a research team that will develop a new technology platform with the potential to transform the field of cancer immunotherapy. The grant aims to support the development of highly innovative technologies that can ultimately be adopted by the research community at large and that will enable researchers to develop the next generation cancer immunotherapies that can be effective and personalized for each patient. Technologies may facilitate our understanding of the antigenic profile, cellular interplay, and mechanistic pathways within the tumor microenvironment that are essential for an effective anti-tumor response.<\/p>\n\n\n\n

About the Cancer Research Institute<\/strong>
The Cancer Research Institute (CRI), established in 1953, is the world\u2019s leading nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system-based strategies to prevent, diagnose, treat, and eventually cure all cancers. Guided by a world-renowned Scientific Advisory Council that includes three Nobel laureates and 26 members of the National Academy of Sciences, CRI has invested $344 million in support of research conducted by immunologists and tumor immunologists at the world\u2019s leading medical centers and universities, and through its global network of scientists and clinicians has contributed to many of the key advances that demonstrate the potential for immunotherapy to change the face of cancer treatment. To learn more, go to cancerresearch.org.<\/p>\n","protected":false},"excerpt":{"rendered":"

CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system<\/p>\n","protected":false},"featured_media":2337,"template":"","tags":[],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11210","cri_news","type-cri_news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nCRI Announces $1 Million Technology Impact Award Recipient - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRI Announces $1 Million Technology Impact Award Recipient - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-13T04:19:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient\",\"url\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient\",\"name\":\"CRI Announces $1 Million Technology Impact Award Recipient - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg\",\"datePublished\":\"2017-06-26T00:00:00+00:00\",\"dateModified\":\"2022-07-13T04:19:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Room Article\",\"item\":\"https:\/\/www.cancerresearch.org\/media-room\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CRI Announces $1 Million Technology Impact Award Recipient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRI Announces $1 Million Technology Impact Award Recipient - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient","og_locale":"es_ES","og_type":"article","og_title":"CRI Announces $1 Million Technology Impact Award Recipient - Cancer Research Institute","og_description":"CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system","og_url":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-13T04:19:07+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient","url":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient","name":"CRI Announces $1 Million Technology Impact Award Recipient - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg","datePublished":"2017-06-26T00:00:00+00:00","dateModified":"2022-07-13T04:19:07+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/45fc9dc1-a745-4432-a63c-0747cd962653.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-1-million-technology-impact-award-recipient#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Media Room Article","item":"https:\/\/www.cancerresearch.org\/media-room"},{"@type":"ListItem","position":3,"name":"CRI Announces $1 Million Technology Impact Award Recipient"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news\/11210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2337"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11210"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=11210"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11210"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11210"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11210"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11210"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}